Greinix, Hildegard
Article History
Accepted: 25 July 2022
First Online: 9 September 2022
Conflict of interest
: H. Greinix: Honoraria for participation in speakers bureau and advisory boards from Gilead, Novartis, Celgene, Sanofi, Takeda, and Therakos.
Free to read: This content has been made available to all.